Aim: To investigate the effects of diltiazem, an L-type calcium channel blocker, and propafenone, a sodium channel blocker, on the inactivation and recovery kinetics of fKv1.4, a potassium channel that generates the cardiac transient outward potassium current. Methods: The cRNA for fKv1.4ΔN, an N-terminal deleted mutant of the ferret Kv1.4 potassium channel, was injected into Xenopus oocytes to express the fKv1.4ΔN channel in these cells. Currents were recorded using a two electrode voltage clamp technique. Results: Diltiazem (10 to 1000 μmol/L) inhibited the fKv1.4ΔN channel in a frequency-dependent, voltage-dependent, and concentration-dependent manner, suggesting an open channel block. The IC 50 was 241.04±23.06 μmol/L for the fKv1.4ΔN channel (at +50 mV), and propafenone (10 to 500 μmol/L) showed a similar effect (IC 50 =103.68±10.13 μmol/L). After application of diltiazem and propafenone, fKv1.4ΔN inactivation was bi-exponential, with a faster drug-induced inactivation and a slower C-type inactivation. Diltiazem increased the C-type inactivation rate and slowed recovery in fKv1.4ΔN channels. However, propafenone had no effect on either the slow inactivation time constant or the recovery. Conclusion: Diltiazem and propafenone accelerate the inactivation of the Kv1.4ΔN channel by binding to the open state of the channel. Unlike propafenone, diltiazem slows the recovery of the Kv1.4ΔN channel.
Introduction
Transient outward potassium currents (I to ) contribute to the early repolarization phase of the cardiac action potential [1, 2] . Two types of I to are known: I to (fast), which shows fast recovery kinetics, and I to (slow), which shows slow recovery kinetics that are related to accumulated inactivations [3] . As the major component of I to (slow), the Kv1.4 channel plays an important role in the repolarization of cardiac myocytes. Kv1.4 channels were inactivated by two well-established processes: Nand C-type inactivation. N-type inactivation results from the occlusion of the intracellular side of the pore by a "ball and chain" mechanism formed by the NH 2 terminus of the channel molecule [4] [5] [6] [7] [8] [9] , while C-type inactivation involves conformational changes on the extracellular side of the pore [10] . These two mechanism are coupled [5] ; C-type inactivation is more rapid in the presence of N-type inactivation [11] and can be affected by open channel blockers. Recovery from inactivation is controlled by the slower C-type mechanism [11] , which makes it physiologically important.
The L-type calcium channel blocker diltiazem and the sodium channel blocker propafenone are widely used in clinics for the treatment of cardiovascular diseases of hypertension, cardiac angina (for diltiazem) and arrhythmias [12] [13] [14] . The therapeutic effects are generally believed to be related to the L-type calcium channel (for diltiazem) and the sodium channel (for propafenone). Recent studies demonstrated that diltiazem inhibited the hKv1.5 channel, which conducts ultra rapid delayed rectifier currents (I kur ), and I to , encoded by Kv4.3 by binding to the open and the inactivated states of the channels [15] [16] [17] . There is evidence that diltiazem decreases Kv1.4 channel currents expressed in the oocytes of Xenopus laevis [16] , and propafenone was shown to be an open channel antagonist of Kv1.4 channel currents [18] , but their detailed characteristics have not been studied.
The present study, in which we used an N-terminal deletion construct of Kv1.4 (Kv1.4ΔN) that lacks rapid N-type inactivation but exhibits robust C-type inactivation [19] , was therefore designed for the following: (1) to study the properties of Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in Xenopus oocytes
Materials and methods

Molecular biology
The constructs and sequences of the cDNA fKv1.4ΔN used in this study have been previously described [19] [20] [21] and were a gift from professor Randall L RASMUSSON (University at Buffalo, SUNY). The construction of fKv1.4ΔN was performed by removal of 2-146 amino acid residues from the N-terminal domain of Kv1. 4 , which results in the loss of the fast component of inactivation but leaves the C-type inactivation pathway intact [19] [20] [21] . Transcribed fKv1.4ΔN cRNA was prepared in vitro using an mMessage mMachine kit (T3 kit, Ambion, USA).
Isolation of oocytes and incubation
Oocytes were collected from mature female Xenopus laevis frogs (Chinese Academy of Science, Beijing, China). Frogs were anesthetized (immersion in 1.5 g/L tricaine) for 30 min, followed by surgical removal of the ovarian lobes through a lateral incision in the lower abdomen. The incision was then sutured, and the frog was allowed to recover in a container with a small amount of water. When the frogs did not produce a high quality of oocytes, they were humanely killed via a high dose of tricaine. All procedures were approved by the Institutional Animal Care and Use Committee of the Wuhan University of China.
The follicular layer was removed enzymatically by placing the ovarian lobes in a collagenase-containing, Ca 2+ -free OR 2 solution (mmol/L: 82.5 NaCl, 2 KCl, 1 MgCl 2 and 5 Hepes, pH 7.4, with 1-1.5 mg/mL collagenase (Type I, Sigma, USA). The oocytes were gently shaken for about 1 h and washed several times with Ca 2+ -free OR 2 solution as previously described [13] . Finally, defolliculated (stage IV) oocytes were selected and placed in ND96 solution (mmol/L): 96 NaCl, 2 KCl, 1 MgCl 2 , 1.8 CaCl 2 and 5 Hepes, pH 7.4. Each oocyte was injected with about 25-50 nL of fKv1.4ΔN cRNA using a microinjector (WPI, Sarasota) and incubated in an 18 °C environment in ND96 solution with 100 IU/mL penicillin for over 16 h.
Electrophysiology
The experiment was carried out using a two electrode voltage clamp technique. Oocytes were clamped using a preamplifier CA-1B (DAGAN, USA), and the current signals were filtered at 2.5 kHz. Microelectrodes were fabricated from 1.5 mm o.d. borosilicate glass tubing using a two-stage puller (NARISHIGE, Japan) to produce electrodes with resistances of 0.5-1.0 MΩ when filled with 3 mmol/L KCl. Currents were recorded at room temperature (20-24 °C) . Recordings were made in 2 mol/L [K + ] o . Diltiazem and propafenone were separately dissolved in distilled water with a stock solution of 100 mmol/L. During recording, oocytes were continuously perfused with a control (ND96) or drug-containing ND96 solution. Whenever drugs were used, 10 min of perfusion time was used to allow equilibration of the drug with the oocytes. After this wash-on period, a series of 500 ms depolarizing pulses (from -90 mV to +50 mV at a frequency of 1 Hz for 1 min) was employed to ensure a steady-state block before beginning the experimental protocols [20] .
Data analysis
Data were recorded with a personal computer installed with pCLAMP 9.0 (Axon, USA) and analyzed using Clampfit 9.0 (Axon, USA) and Microsoft Excel software (Microsoft, USA). Unless otherwise stated, raw data traces were not leakage or capacitance subtracted. Data are shown as means±SEM. Significant differences were determined using Student's paired t-tests.
Results
Effects of diltiazem on fKv1.4ΔN currents Voltage-, concentration-, and frequency-dependent blockade of diltiazem on fKv1.4ΔN currents Figure 1A shows representative fKv1.4ΔN current traces recorded by applying 5 s pulses from -100 mV to +50 mV in 10 mV increments in the control, in the presence of 250 μmol/L diltiazem, and after the drug washout. The fKv1.4ΔN currents were substantially inhibited by the application of 250 μmol/L diltiazem and the effect recovered after washout of the drug for 10 min. Peak-voltage relationships from the control, 250 μmol/L diltiazem-treated and drug washout oocyte groups were plotted against clamp potential in Figure 1B . In this figure, the I DIL /I CON ratio was plotted as a function of the membrane potential. Diltiazem decreased the peak currents at transmembrane potentials positive to the activation threshold (-30 mV). The blockade increased steeply in the voltage range coinciding with that of channel activation (between -40 mV and -20 mV) and remained constant at voltages above this range. The peak current was blocked by 52.21%±4.63% when the cell membrane was depolarized to +50 mV in 250 μmol/L diltiazem, and the effect was reversed by 95% after the drug washout. There was a voltage dependence to the action of diltiazem, a phenomenon typical of open channel block. Figure 1C shows the concentration dependence of fKv1.4ΔN current inhibition by diltiazem. Inhibition of the currents in a concentration-dependent manner was measured at the end of a 300 ms pulse of +50 mV. A nonlinear least-squares fit of the Hill equation to the individual data points yielded an apparent dissociation constant, K D , for an open channel blockade of 241.04±23.06 μmol/L (n=5).
To evaluate the longer-term effects of exposing the fKv1.4ΔN channel to diltiazem, we applied a series of 500 ms depolarizing pulses from -90 mV to +50 mV with a frequency of 1 Hz for a period of 1 min. Figure 2 shows the peak currents elicited by this protocol, before and after exposure to 250 μmol/L diltiazem, normalized to the first peak current under control conditions. With increasing pulse numbers, currents in both the control and the diltiazem-treated groups decreased. The first pulse of the pulse train in the presence of 250 μmol/L were normalized to the maximum control value without drug and plotted in Panel C. As pulse number increased, currents in both control and diltiazemtreated groups decreased. In control cells, there was a use-dependent reduction in the magnitude of the peak current. When cells were exposed to 250 μmol/L diltiazem for 10 min before stimulation, there was a reduction in the magnitude of the first peak current compared to the control value and then a use-dependent component. The use-dependent reduction in current with diltiazem was much greater than that seen in control.
www.nature.com/aps Zhang D et al Acta Pharmacologica Sinica npg diltiazem showed a decrease relative to the pre-drug control, and the magnitude of this reduction in current was similar to that seen under steady-state conditions when a sufficiently long recovery time was allowed between test pulses. In both the control and the 250 μmol/L diltiazem protocols, there was a use-dependent decrease in the peak current when stimulated at 1 Hz, but this use-dependent decrease was considerably greater in 250 μmol/L diltiazem than under the control conditions. In control oocytes, the peak current decayed monoexponentially from 100% to 78.86%. In contrast, in 250 μmol/L diltiazem the current decayed from 44.14% to 23.07%. Figure 3A shows the time-dependent progression of the channel from the rapid open block conformation into a diltiazeminduced block during a single depolarizing step from -90 mV to +50 mV. For comparison, all current traces were normalized to the peak values under control conditions. In control conditions, the rate of inactivation of fKv1.4ΔN was monoexponential with a time constant of 2.32±0.41 s (n=6). In the presence of 10 to 1000 μmol/L diltiazem, inactivation became bi-exponential, with a dominant fast exponential. Figure 3B (a) shows steady-state inactivation as a function of holding potential for the fKv1.4ΔN channel both before and after exposure to diltiazem. The relationships were determined from the two pulse protocol by calculating the ratio of the magnitude of the peak current in P 2 to the maximum of the P 2 obtained when P 1 was -100 mV. In this panel, diltiazem can be seen to shift the voltage dependence of inactivation to the left. In order to correct the visual error caused by different minimum values, the steady-state inactivation relationships were renormalized [ Figure 3B (b)], thus preferably displaying the drift of the steady inactivation curve before and after diltiazem treatment. Figure 3B (b) also shows this shift to the left. The half-inactivation (V 1/2 ) and slope factor (k) values from We found that C-type inactivation was obviously accelerated by 250 μmol/L diltiazem at +50 mV. Over the range 0 mV to +50 mV, there is no voltage sensitivity to τ inactivation (P>0.05, n=6). In the presence of diltiazem, τ fast is voltage independent, whereas τ slow is voltage dependent. The time constant of C-type inactivation changes was independent of voltage, indicating that C-type inactivation of the fKv1.4ΔN channel is at least partly independent on activation. Thus, above 0 mV, C-type inactivation has nothing to do with the degree of depolarization of membrane voltage; however, C-type inactivation becomes correlated to activation in the presence of diltiazem. Figure 4C shows the plot of the 1/τ block as a function of the diltiazem concentration for data obtained at concentrations between 10 μmol/L and 1000 μmol/L. The straight line is the least-squares fit to the equation (1/τ block =k +1 [d]+k -1 ). Slope and intercept with the ordinate axis for the fitted relation yielded a k +1 and k -1 of (0.01±0.002)×10 6 (mol/L) -1 ·s -1 and 
Effect of diltiazem on the steady inactivation of peak Kv1.4ΔN currents
Effects of diltiazem on the recovery kinetics of fKv1.4ΔN currents
The rate of recovery from inactivation of the Kv1.4 channel is governed by recovery from C-type inactivation. We measured the effect of diltiazem on the rate of recovery from inactivation in the fKv1.4ΔN channel using a standard gapped pulse protocol with a variable interstimulus interval. The ratio of the magnitude of the first and second pulse peak currents was used as an indication of the degree of the recovery from inactivation. Figure 5A shows the fraction of fKv1.4 channels recovered plotted against the interstimulus interval. In the presence of 250 μmol/L diltiazem, there is a dramatic decrease in the rate of recovery of fKv1.4ΔN channels when compared to the control. The envelope of peak ratios was best fitted with a monoexponential function. The presence of 250 μmol/L diltiazem increased the time constant for the rate of recovery from inactivation in fKv1.4ΔN. The mean time constants for recovery were 1.73±0.10 s (n=5) in the control and 2.66±0.14 s (n=5) in the diltiazem treated group (P<0.05; Figure 5B ). The half time constant of recovery (t 1/2 ) for fKv1.4ΔN was 1.01±0.03 s in the control and 1.67±0.05 s in the presence of 250 μmol/L diltiazem (n=5, P<0.05; Figure 6 ). Diltiazem shifted the recovery from inactivation curve to the right and slowed the recovery time constant and t 1/2 . Figure 5 . Effect of diltiazem on the rate of recovery from inactivation in fKv1.4ΔN. Recovery from inactivation was measured using a standard variable interval gapped pulse protocol. An initial 5 s pulse (P 1 ) from -90 mV to +50 mV was followed by a second pulse (P 2 ) to +50 mV after an interval of between 0.1 s and 20 s. (A) The ratio of the peak current elicited by the P 1 and P 2 pulses (P 2 /P 1 ) is plotted against pulse interval to show the recovery from inactivation. The recovery of inactivation was best fitted using the function: f=1-A*exp(-τ/t), where t is duration (in s), τ is the time constant, A is the amplitude of the current. Recovery curves for fKv1.4ΔN and fKv1.4ΔN+diltiazem, holding potential=-90 mV. (B) Comparison of recovery rate data from fKv1.4ΔN without and with 250 μmol/L diltiazem. The mean time constants for recovery were 1.73±0.10 s (n=5) in control and 2.66±0.14 s (n=5) in the diltiazem treated group ( b P<0.05 vs control). Figure 7A shows typical fKv1.4ΔN current traces recorded by applying 5 s pulses from -100 mV to +50 mV followed by the tail currents obtained upon repolarization to +50 mV under control conditions, in the presence of 100 μmol/L propafenone, and after the drug washout. As shown, 100 μmol/L propafenone decreased fKv1.4ΔN currents, with the effect recovered upon a 10 min washout. Peak-voltage relationships under control conditions, 100 μmol/L propafenone, and after washout are shown in Figure  7B . In this figure, the I PRO /I CON ratio is plotted as a function of the membrane potential. Propafenone substantially decreased the current amplitude at potentials positive to -30 mV. The I PRO /I CON ratio was plotted as a function of the membrane potential; the blockade increased steeply in the voltage range coinciding with that of channel activation (between -40 mV and -20 mV), and it remained constant thereafter. The peak current was blocked by 51.82%±2.35% when depolarized to +50 mV in 100 μmol/L propafenone, and the effect was reversed by 96% after the drug washout. To determine the longer-term effects of exposing the fKv1.4ΔN channel to propafenone, we applied a series of 500 ms depolarizing pulses from -90 mV to +50 mV with a frequency of 1 Hz for a period of 1 min. Figure 8 shows the peak currents recorded by this protocol, before and after exposure to 100 μmol/L propafenone, normalized to the first peak current under control conditions. With increasing pulse numbers, the currents in both the control and the propafenone-treated groups decreased. The first pulse of the pulse train in the presence of 100 μmol/L propafenone showed a decrease relative to the pre-drug control, and the magnitude of this reduction was similar to that seen under steady-state conditions when an adequately long recovery time was allowed between test pulses. In both the control and the 100 μmol/L propafenone protocols, there was a use-dependent decrease in the peak current when stimulated at 1 Hz, but this use-dependent decrease was much greater in 100 μmol/L propafenone than in the control. In control oocytes, the peak current decayed mono-exponentially from 100% to 74.52%. By contrast, in 100 μmol/L propafenone, the current decreased from 49.72% (due to initial rapid open channel block) to 35.20% in the steady state.
Effect of propafenone on the steady inactivation of peak Kv1.4ΔN currents
The time-dependent progression of the channel from the rapid open block conformation into a propafenone-induced block was studied during a single depolarizing step from -90 mV to +50 mV ( Figure 9A ). For comparison, all current traces were normalized to the peak values under control conditions. In control conditions, the rate of inactivation of fKv1.4ΔN was mono-exponential with a time constant of 2.32±0.41 s (n=6). In the presence of 10 to 500 μmol/L propafenone, inactivation became bi-exponential, with a dominant fast exponential. Figure 9B (a) shows the inactivation curves in the absence and presence of 100 μmol/L propafenone. The steady-state inactivation relationships were determined from the two pulse protocol by calculating the ratio of the magnitude of the peak current in P 2 to the maximum of the P 2 obtained when P 1 was -100 mV. In this panel, propafenone can be seen to shift the voltage dependence of inactivation to the left. However, after steady-state inactivation relationships were renormalized [ Figure 9B (b)], we found that propafenone did not shift the voltage dependence of inactivation. Under control conditions, the V 1/2 and K values averaged -41.29±5.21 mV and 1.13±0.09 (n=6), and 100 μmol/L propafenone did not modify either the V 1/2 (-50.62±6.77 mV) or the K (1.62±0.27) (n=6) [ Figure 10A(a  and b) ].
Inactivation of fKv1.4ΔN is best fitted by a single exponential function ( Figure 10B) , with τ inactivation =2.32±0.41 s (n=6) at +50 mV. In the presence of propafenone, the inactivation of fKv1.4ΔN is best fitted with a bi-exponential function, with τ fast =0.44±0.03 s and τ slow =2.23±0.23 s (n=6) at +50 mV [ Figure  10A (c)]. We found that C-type inactivation was not shifted by 100 μmol/L propafenone at +50 mV. Over the range of 0 mV to +50 mV, there was no voltage sensitivity to τ inactivation (P>0.05, n=6). In the presence of propafenone, both τ fast and τ slow were voltage independent. Figure 10C shows the plot of the 1/τ block as a function of the propafenone concentration for data obtained at concentrations between 10 μmol/L and 500 μmol/L. The straight line is the least-squares fit to the equation (1/ , respectively.
Effects of propafenone on the recovery kinetics of fKv1.4ΔN currents
The effects of propafenone on the recovery kinetics of the fKv1.4ΔN channel expressed in Xenopus oocytes are presented in Figure 11A . The fraction of fKv1.4 channels recovered was plotted against the interstimulus interval. The mean time constants of recovery from the steady-state inactivation were 1.78±0.09 s (n=5) in the control and 1.86±0.14 s (n=5) in the propafenone treated group (P>0.05; Figure 11B ). In the presence of 100 μmol/L propafenone, there is no significant change in the rate of recovery of fKv1.4ΔN compared to the control. The half time constant of recovery for fKv1.4ΔN was 1.14±0.04 s in the control and 1.49±0.05 s in the presence of 100 μmol/L propafenone (n=5, P>0.05; Figure 12 ). These results Figure 8 . Frequency-dependent block of fKv1.4ΔN channel by propafenone. Currents were elicited by using a series of depolarising pulses from -90 mV to +50 mV with a frequency of 1 Hz in the absence (A) and in the presence of 100 μmol/L propafenone (B). The peak currents shown in Panel A and B were normalized to the maximum control value without drug and plotted in Panel C. As pulse number increased, currents in both control and propafenone-treated groups decreased. In control cells, there was a use-dependent reduction in the magnitude of the peak current. When cells were exposed to 100 μmol/L propafenone for 10 min before stimulation, there was a reduction in the magnitude of the first peak current compared to the control value and then a use-dependent component. The use-dependent reduction in current with propafenone was obviously greater than that seen in control.
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Discussion
The L-type calcium channel blocker diltiazem and the sodium channel blocker propafenone have been reported to block several cloned potassium channels, including Kv1.1, Kv1.2, Kv1.4, Kv1.5, Kv2.1, Kv4.2, and hERG channel currents [16, [21] [22] [23] [24] . For instance, diltiazem, at concentrations of 0.01 nmol/L to 500 μmol/L, suppressed the hKv1.5 potassium channel expressed in mouse fibroblasts with an estimated IC 50 of 42.3 μmol/L [17] . But in human atrial myocytes, I Kur was blocked by diltiazem at relatively low concentrations (IC 50 =11.2 μmol/L) [25 ] . In Chinese hamster ovary cells, diltiazem (109.9 μmol/L) was reported to suppress the Kv4.3 channel by 50% [17] . Diltiazem blocked I to (fast) in human atrial myocytes with an IC 50 of 29.2 μmol/L [26] . Propafenone was shown to depress hERG channel currents in human embryonic kidney cells with an IC 50 of 440 μmol/L [22] , and it was shown to block hKv1.5 channels in a concentration-, voltage-, time-and use-dependent manner with an IC 50 value of 4.4 mmol/L [23] . Propafenone was also shown to inhibit I to in rabbit atrial myocytes and rat ventricular myocytes [26] , as well as to inhibit the hyperpolarizationactivated inward current in isolated human atrial myocytes [27] and I Kr in sinoatrial node cells, rabbit atrial myocytes and guinea pig ventricular myocytes [26, [28] [29] . Limited data are available for the Kv1.4 potassium channel. In Xenopus oocytes, diltiazem and propafenone have been reported to reduce fKv1.4 potassium channel currents, and 100 μmol/L diltiazem and 100 μmol/L propafenone were reported to suppress Kv1.4 potassium channel tail currents by 10% and 11%, respectively [16] . Propafenone was shown to be an open channel antagonist of Kv1.4 channel currents [18] , but the mechanism of the drug block was not examined. Our find- Currents were recorded by using 1 s pulses from -90 mV to +50 mV in the absence and presence of increasing concentrations of propafenone. For comparison, all current traces were normalized to the peak values under control conditions. The smooth continuous line superimposed on each trace is the best fit of an exponential function, used to determine the inactivation time constant (s). The control trace was best fitted by a mono-exponential function (Chebyshev method) (a), whereas in the presence of 10-500 μmol/L propafenone, inactivation was best fitted by a bi-exponential function (Levenberg-Marquardt) (b-f). (B) Steady-state inactivation relationships (a). The steady-state inactivation for each P 1 voltage was calculated as the magnitude of the peak current in P 2 compared with that from the maximum of the P 2 obtained when P 1 ings agree with these reports; however, we found that blockade required relatively high drug concentrations. In the current study, it has been shown that both diltiazem and propafenone are blockers of the fKv1.4 channel. Starting with concentrations of 10 μmol/L, up to 50% of the fKv1.4 channel currents were blocked with 241 μmol/L diltiazem and 103 μmol/L propafenone. Although the concentrations required were higher, in interpreting the results, it has to be further considered that in the oocyte expression system, a fivefold to ten fold higher concentration of antiarrhythmic drugs is needed to obtain an effect comparable to that seen in mammalian cells lines [16] . Thus, it can be assumed that in cardiomyocytes, both diltiazem and propafenone have an even stronger effect on the Kv1.4 channel than that reported in this study in Xenopus oocytes.
Diltiazem and propafenone are different types of antiarrhythmic drugs. The electrophysiological effects of the two drugs on fKv1.4ΔN channel inactivation have been determined. Both drugs decrease fKv1.4ΔN channel currents in voltage-, concentration-, and frequency-dependent manners. However, the difference between the two drugs is three fold. First, our results have demonstrated that diltiazem exhibits a similarly high affinity for fKv1.4 channels and that the concentration of blockade is slightly higher than that needed to block L-type calcium channels [16] , while propafenone exhibits a higher binding affinity for fKv1.4 channels compared with diltiazem. Second, in the presence of diltiazem, the magnitude of the peak current is obviously reduced, and the rate of inactivation is increased compared with the control. The τ inactivation values we found were 2.32±0.21 s and 1.78±0.19 s in the absence and presence of 250 μmol/L diltiazem, respectively; however, 100 μmol/L propafenone did not increase the C-type inactivation time constant. Third, diltiazem slows recovery from inactivation, but propafenone has no effect on this process. Diltiazem induced a voltage-dependent block of fKv1.4 channels that increased over the voltage range of channel activation. When channel activation reached saturation, the block induced by diltiazem remained increased, an effect that resembles the action of propafenone on fKv1.4 [18] , and there was a voltage dependence to the action of both drugs.
The rate of fKv1.4 current decay in the control could be fitted to a single exponential function, and in the presence of diltiazem and propafenone, the inactivation became biexponential, characterized by the extremely fast drug-induced inactivation and the relatively slower C-type inactivation. The diltiazem-induced C-type inactivation was much faster than that seen under control conditions, which may be explained by the mechanism in which binding of drug to the intracellular site of the channel triggers a conformational change at the external mouth of the pore that facilitates C-type inactivation. This phenomenon was also observed in the same channel induced by quinidine and verapamil [18, 20] . However, propafenone did not increase the C-type inactivation time constant, demonstrating that binding of propafenone to the channel did not induce a conformational change at the external mouth of the pore.
The two drug-induced extra component of inactivation [rapid inactivation(τ fast )] had a time constant that was much faster than that of slow inactivation; therefore, this fast time constant can be considered to represent the interaction of the drug with the open state. Using the time constants of development for fKv1.4 blockade obtained in the range of 10-1000 μmol/L (for diltiazem) and 10-500 μmol/L (for propafenone), the k +1 and k -1 constants for diltiazem and propafenone were obtained. Assuming a first order reaction drug/channel inter- Figure 11 . Effect of propafenone on the rate of recovery from inactivation in fKv1.4ΔN. Recovery from inactivation was measured using a standard variable interval gapped pulse protocol. An initial 5 s pulse (P 1 ) from -90 mV to +50 mV was followed by a second pulse (P 2 ) to +50 mV after an interval between 0.1 and 20 s. (A) The ratio of the peak current elicited by the P 1 and P 2 pulses (P 2 /P 1 ) is plotted against pulse interval to show the recovery from inactivation. The recovery of inactivation was best fitted using the function: f=1-A*exp(-τ/t), where t is duration (in s), τ is the time constant, A is the amplitude of the current. Recovery curves for fKv1.4ΔN and fKv1.4ΔN+propafenone, holding potential=-90 mV. [30, 31] . This estimate was independent of but similar to the IC 50 calculated from the respective concentration-response curve. The similarity of the IC 50 values obtained by the two independent methods supports the open-channel block model used to calculate the rate constants for the Kv1.4 channel. Diltiazem and propafenone-induced blockade of Kv1.4 channels developed during depolarization, and no blockade happened when the channel closed, which strongly suggests that both drugs are open state blockers of the Kv1.4 channel.
From this study, we found that diltiazem blockade of the fKv1.4ΔN channel was a complex process that may involve more than one conformational state. First, diltiazem blocks the open channel with rapid kinetics as fast as activation kinetics because diltiazem does not change the steady state activation. Second, diltiazem binds to the channel and blocks it in a voltage-and time-dependent manner. Finally, the binding of diltiazem to the channel enhances C-type inactivation. Based on previous results showing that retardation of C-type inactivation dramatically reduced E-4031 binding affinity in hERG channels [32] , we concluded that an interaction between drug binding and C-type inactivation exists.
Clinically, diltiazem is widely used as an anti-arrhythmic and anti-anginal drug. It has been reported that the cardiac action potentials in mice were lengthened by 10 nmol/L diltiazem, a finding that may be explained by diltiazem-induced blockade of the I to (slow) currents generated by the Kv1.4 channel [33] . The Kv1.4 channel, as the major component of I to (slow), which in turn is a major contributor to phase 1 and the early part of phase 2 of the action potential, plays an important role in the repolarization of the endocardial region of the left ventricle [34] . Therefore, the reduction of Kv1.4 induced by diltiazem prolongs action potential durations. Propafenone has a similar effect.
In this study, we found that in response to the faster frequency stimulations, fKv1.4ΔN channel currents were significantly reduced. Opening the channel with a faster frequency may facilitate entry of the drug into the channel. These conformation-specific drug-binding properties lead to some clinically important issues, such as use dependence. The effects of micromolar diltiazem on fKv1.4 are moderate but are likely to be enhanced during tachyarrhythmias due to the frequency dependence of the drug's action, and propafenone shares these characteristics. Decreasing recovery rates could attenuate the shortening of the action potential duration caused by diltiazem-induced inhibition of L-type calcium channels. Because diltiazem and propafenone have different antiarrhythmic effects, their blockade actions on the Kv1.4ΔN channel must be considered when diltiazem is applied in combination with propafenone or other potassium channel blockers such as amiodarone.
